Winter savory

Winter Savory (Satureja montana L.): A Comprehensive Reference

1. Identity and Botanical Description

Taxonomy and Nomenclature

Winter savory, known botanically as Satureja montana L., is a perennial, semi-evergreen herb in the family Lamiaceae, native to warm temperate regions of southern Europe, the Mediterranean, and Africa. The herb was first formally published by Carl Linnaeus in his work Species Plantarum in 1753. The Latin specific epithet montana refers to mountains or coming from mountains, giving rise to the common name "mountain savory." Within the broader Satureja genus, winter savory is distinguished from its close annual relative, the summer savory (Satureja hortensis L.), which is an annual plant.

Common names for S. montana in different languages include "santoreggia" in Italian (with regional variants "santorin" and "anchovy herb"), "sarriette des montagnes" in French, and "saturejka horská" in Czech. Plants of two species of Satureja—S. hortensis and S. montana—which produce essential oils rich in carvacrol, are employed mainly as culinary herbs under the common name "savory."

Morphology and Growth Habit

Winter savory is a dwarf, woody-stemmed, shrubby perennial prized for its stiff, narrowly lance-shaped, aromatic, dark green leaves, which can be used fresh or dried to flavor food. It grows to between 10 and 40 cm tall. The leathery, dark green leaves are opposite, oval-lanceolate or needle-like, 1–2 cm long and 5 mm broad. The flowers appear in summer, between July and October, and range from pale lavender or pink to white.

The plant can be found growing on old walls, dry banks and rocks on hillsides, or rocky mountain slopes, usually on calcareous or alkaline soils. Its natural range includes temperate Asia (Lebanon, Syria, Turkey) and much of Europe including Austria, former Yugoslavia, Albania, Greece, Italy, Romania, Spain, and France. It also grows wild on mountain ranges in the Adriatic area, such as the Dinaric Alps and the Apennine Mountains, across Italy, Slovenia, Croatia, Bosnia and Herzegovina, Serbia, Montenegro, and Albania, as well as in the Pyrenees in France and Spain.

Subspecies and Chemotypic Variability

Two recognized subspecies exist: S. montana subsp. montana and subsp. variegata. The wide range of distribution, and the influence of microclimatic and edaphic conditions and crossover with other Satureja species, has led to high variability in the botanical characteristics and chemical composition within the populations. This chemotypic variability is biologically significant: a mixed carvacrol–thymol chemotype (with both compounds at 20–40%) is frequently found in transitional zones. These results underscore the significant impact of both chemotype and extraction technique on the bioactive profile of S. montana extracts, and optimizing extraction based on chemotype is thus crucial for enhancing therapeutic efficacy.

Common Forms and Preparations

Winter savory is commercially available and used in several forms:

• Fresh and dried herb: A small evergreen shrub; the leaves have a peppery, tangy, marjoram-like flavor and are used mainly as a flavoring for cooked foods, especially beans, and also as a garnish for salads. The leaves can be used fresh or dried, making a great herbal tea.
• Essential oil (EO): Produced primarily by steam distillation of the aerial parts; this is the most studied form pharmacologically.
• Hydrolate (floral water): A byproduct of steam distillation; hydrolate (HY) preparations have been investigated alongside essential oils in extraction studies.
• Aqueous and hydroalcoholic extracts / decoctions: Prepared by infusion or decoction of the dried herb; these are rich in polar phenolic compounds such as rosmarinic acid.
• Dry/standardized extract: Produced for pharmaceutical or supplement use, typically concentrated in rosmarinic acid.
• Culinary blend ingredient: Savory is a key herb in Herbes de Provence, a famous French blend of dried herbs native to Provence, alongside marjoram, rosemary, thyme, and oregano.

2. Historical and Traditional Use

Ancient Greece and Rome

There is evidence of the use of savory about 2,000 years ago by the ancient Greeks and Romans. Winter savory has a long and esteemed history in traditional herbal medicine, dating back to ancient Greece and Rome. Esteemed by both Greek and Roman physicians, it was considered a staple remedy for digestive ailments, such as indigestion, flatulence, and loss of appetite. Historical records suggest that the Romans were particularly fond of savory, utilizing it in a variety of dishes and sauces to add a peppery zest.

Medieval Europe and Monastery Gardens

In medieval Europe, winter savory was often cultivated in monastery gardens as part of the essential collection of healing herbs. The Saturejas have been traditionally used to strew on the floor since medieval times, as an aromatic herb that reduces insects. In traditional herbal medicine, summer savory was believed to be an aphrodisiac, while winter savory was believed to inhibit sexual desire (an anaphrodisiac).

Balkan and Mediterranean Folk Medicine

Satureja montana and S. subspicata (Lamiaceae) are used for centuries in traditional medicine of Balkan peoples in the healing of the lymphatic nodule and respiratory system inflammation. Tertiary resources document both summer and winter savory having a history of use in traditional medicine as tonics, carminatives, astringents, and expectorants, and for the treatment of intestinal problems such as diarrhea and nausea.

Essential oil of winter savory was applied in treatment of nausea, sore throat, rheumatism, gout, colic, and flatulence. Tea made of winter savory was used in treatment of uterine contractions, menstrual irregularities, cough, gastric problems, as well as disorders of the kidney and liver.

Broader Traditional Preparations

Folk remedies frequently utilized it in the treatment of sore throats, coughs, and minor respiratory complaints. The herb was sometimes brewed into teas or used as a poultice to support wound healing, thanks to its reputed ability to combat infection. The essential oil has also been used as an ingredient in lotions for the scalp in cases of incipient baldness. An ointment made from the plant has been used externally to relieve arthritic joints.

3. Key Constituents and Active Compounds

Volatile / Essential Oil Fraction

The main compounds derived from Satureja montana can be categorized into several classes. From the group of monoterpenes, carvacrol, p-cymene, γ-terpinene, and thymol are found. Oxygenated monoterpenes are represented by carvacrol methyl ether, borneol, and linalool. Of the sesquiterpenes, β-caryophyllene is present in concentrations ranging from 2.74% to 4.71%, and spathulenol is found in smaller amounts.

GC/MS analysis revealed 33 compounds, with the major fraction being monoterpenes. The oxygen-containing phenolic monoterpene carvacrol (50.2%) was found to be the main constituent, followed by thymol (11%), γ-terpinene (5.8%), carvacrol methyl ether (4.6%), and p-cymene (4.8%). In another GC-MS study, S. montana essential oil primarily contained carvacrol (43.72%), γ-terpinene (17.24%), and p-cymene (14.56%).

A study published on PubMed used untargeted FT-ICR mass spectrometry and GC-MS to profile a commercial S. montana essential oil, identifying carvacrol, cymene, and thymol as the major components.

Non-Volatile Phenolic Fraction

The main phenolic acid components isolated from savory are rosmarinic and ellagic acids. Phenolic compound profiling by HPLC identified eight phenolic compounds in methanolic and ethanolic extracts: rutin, quercetin, caffeic acid, p-coumaric acid, ellagic acid, protocatechuic acid, rosmarinic acid, and syringic acid. Rosmarinic acid and small quantities of carvacrol were identified as the primary constituents found in the dry extract of Satureja montana. MAE (microwave-assisted) extracts exhibit the highest total polyphenol content (TPC) and total flavonoid content (TFC), with the highest concentrations of rosmarinic acid and rutin, along with superior antioxidant activity measured by ion exchange-based assays (FRAP and CUPRAC).

Summary Table of Key Constituents

• Carvacrol — dominant phenolic monoterpene in the essential oil (reported 43–50%+); primary carrier of antimicrobial activity.
• Thymol — co-dominant phenolic monoterpene (up to ~11–16% in S. montana); contributes antimicrobial and antioxidant effects.
• γ-Terpinene and p-cymene — monoterpene hydrocarbons serving as precursors to carvacrol and thymol.
• Rosmarinic acid — major polyphenolic acid in non-volatile extracts; principal antioxidant and anti-inflammatory compound.
• Ellagic acid, caffeic acid, rutin, quercetin — secondary polyphenols and flavonoids contributing to antioxidant capacity.
• β-Caryophyllene — sesquiterpene present at 2.74–4.71%; associated with anti-inflammatory activity.
• Borneol, linalool, carvacrol methyl ether — minor oxygenated monoterpenes.

4. Mechanisms of Action

Antimicrobial and Antifungal Mechanisms

The essential oil of Satureja montana is a natural substance able to inhibit the growth of several pathogens. This antimicrobial effect is often attributed to its ability to penetrate cellular structures and disrupt them. Both aqueous decoction extracts were found to have rosmarinic acid as the main phenolic compound and to exert their antimicrobial activity at the level of the cell membrane. Membrane perturbations by the extracts impaired cell membrane integrity only a few hours after exposure.

Carvacrol and thymol are terpenoids with proven antimicrobial properties in bacteria and fungi, suggesting that the hydrolate may show high bioactivity. The greater susceptibility of Gram-positive bacteria is structurally explained: the sensitivity of Gram-positive bacteria to S. montana was consistent with published research; the lower susceptibility of Gram-negative bacteria, such as Pseudomonas aeruginosa, can be explained by cell membranes rich in hydrophilic lipopolysaccharides.

In studies with Campylobacter jejuni, six pure compounds—carvacrol, thymol, thymoquinone, p-cymene, γ-terpinene, and rosmarinic acid—were identified in the herb's chemical profile. The antimicrobial activity of the ethanolic extract (MIC 250 mg/L) was 4-fold higher compared to the essential oil.

Antioxidant Mechanisms

Research has confirmed the presence of free radical-scavenging activity through three distinct in vitro methods, leading researchers to classify dry extract of S. montana as an effective antioxidant. Notably, S. montana exhibited superior antioxidant activity compared to other species within Satureja sp. Stronger antioxidant activity has been reported for ethanolic and aqueous extracts compared to the essential oil, explained by the higher content of phenolic acids such as rosmarinic and others which, due to their hydroxyl groups, have a strong capability of capturing free radicals.

Anti-Inflammatory Mechanisms

It was determined that S. montana possesses a local anti-inflammatory effect comparable to that of diclofenac. S. montana demonstrates a propensity to lower serum levels of IL-6, IL-1β, and TNF in both acute and chronic stress models. The authors proposed that inhibition of cyclooxygenase is the most probable mechanism underlying this action.

Satureja fatty acids had different modulatory effects on NF-κB and NRF2 pathways, significantly lowering NF-κB expression while raising NRF2 expression in treated cells.

Cholinesterase Inhibitory (Neuroprotective) Mechanisms

In a comparative analysis of different species within the Lamiaceae family, Satureja montana emerged as one of the plants demonstrating significant acetylcholinesterase inhibitory activity at a concentration of 1 mg/mL. Additionally, essential oils from S. montana inhibited human serum cholinesterase activity, indicating the potential for treating neurological diseases. Further, extracts obtained through supercritical fluid extraction showed significant inhibition of butyrylcholinesterase (BChE).

In a dedicated comparative study, S. montana essential oil demonstrated notable inhibition of AChE (32.58%) and BChE (41.62%) at 1000 µg/mL. These phenolic monoterpenes are considered likely contributors to the observed antioxidant and cholinesterase inhibitory activities.

5. Scientific Evidence by Area of Use

Important caveat: The great majority of published research on Satureja montana is preclinical (in vitro cell studies or animal models). Clinical evidence in humans is very limited for most areas. This is clearly noted under each section.

5.1 Antimicrobial Activity

Evidence type: In vitro; limited in vivo animal data. No controlled human clinical trials identified.

This is the most extensively studied pharmacological property of S. montana. Essential oils from the genus Satureja have recognized biological properties, including analgesic, anti-inflammatory, immunomodulatory, anticancer, and antimicrobial activity.

One study evaluated the antimicrobial activity of decoctions of Satureja montana and Origanum majorana against Gram-positive and Gram-negative bacteria and Candida spp., as well as their mechanism of action and phenolic characterization. The Satureja montana and Origanum majorana extracts were effective against a broad set of species, including the Gram-positive Staphylococcus aureus, Enterococcus faecalis, and Streptococcus dysgalactiae, and the Gram-negative Klebsiella pneumoniae and Pseudomonas aeruginosa.

Satureja montana and Origanum majorana decoctions presented MIC and MBC values of 1.56 mg/mL against S. aureus and K. pneumoniae, suggesting bactericidal features. Satureja montana decoction presented MIC and MFC values of 6.25 mg/mL against Candida, exhibiting a lower antimicrobial effect comparatively.

One PubMed-indexed study evaluated antimicrobial properties of commercial S. montana essential oil alone and in combination with gentamicin toward Gram-negative and Gram-positive bacterial strains. The oil's metabolite profile was characterized by FT-ICR MS and GC-MS, identifying carvacrol, cymene, and thymol as major components. The essential oil exerted antimicrobial activity and induced a synergistic interaction with gentamicin against both reference and clinical bacterial strains.

The antimicrobial and cytotoxic activities of the essential oil of Satureja montana ssp. pisidica from two localities were studied. Forty-nine components were identified; oxygenated monoterpene hydrocarbons—specifically carvacrol, thymol, carvacrol methyl ether, and beta-linalool—were the major compounds. Both tested essential oils showed very high and similar antimicrobial activity. Minimal inhibitory concentrations ranged from 12.5 µg/mL against S. epidermidis to 50 µg/mL against P. aeruginosa and C. albicans.

Regarding antifungal activity in food contexts: S. montana essential oil was evaluated for antifungal and antimycotoxigenic activities against Aspergillus flavus and Aspergillus ochraceus, as well as effects on ergosterol synthesis and membrane morphology. The antifungal potential was evaluated by mycelial growth analysis and scanning electron microscopy. Fungicidal effects against A. flavus were observed, with a minimum fungicidal concentration (MFC) of 0.98 µL/mL.

Strength of evidence: Strong in vitro data across multiple independent laboratories. Synergistic activity with antibiotics has been demonstrated in lab settings. However, no randomized controlled trials (RCTs) or clinical studies in human patients have been identified for infectious disease treatment.

5.2 Antioxidant Activity

Evidence type: In vitro; some in vivo animal data. No human clinical trials identified.

Studies on populations of S. montana from Croatia examined total phenols and flavonoids by UV/Vis spectrophotometry, phenolic compound profiles by HPLC, and antimicrobial and antioxidant activities. Results showed that the species contained polyphenolics and other antioxidant compounds with chelating and radical-scavenging properties.

In a comparative evaluation, S. montana herb water extract and methanol extract showed the highest DPPH• radical scavenging activity (36.28% and 24.37%, respectively) among the preparations tested.

Both in vitro and in vivo studies demonstrated S. montana's ability to neutralize free radicals and to influence the endogenous antioxidant system.

Strength of evidence: Consistently demonstrated in vitro across multiple assay types (DPPH, ABTS, FRAP, CUPRAC). Translational relevance to human health requires clinical investigation.

5.3 Anti-Inflammatory Activity

Evidence type: In vitro and animal models only. No human clinical trials identified.

Animal and in vitro studies have established that S. montana possesses a local anti-inflammatory effect comparable to that of diclofenac. It lowers serum levels of IL-6, IL-1β, and TNF in both acute and chronic stress models. The inhibition of cyclooxygenase is proposed as the most probable mechanism underlying this action.

In a model of acute stress, dry extract of Satureja montana administered at a dosage of 250 mg/kg markedly reduced the concentrations of pro-inflammatory cytokines, including TNF-α and IL-6, when compared to other substances such as isolated carvacrol and rosmarinic acid.

Strength of evidence: Preliminary preclinical evidence across in vitro and animal models. The anti-inflammatory potency appears to involve multiple pathways (COX inhibition, NF-κB suppression, NRF2 upregulation). No human trials have been published.

5.4 Neuroprotective Activity and Cognitive Function

Evidence type: In vitro and animal models; one systematic review of preclinical data. No human clinical trials identified.

Satureja montana is distinguished by a rich variety of secondary metabolites displaying a broad spectrum of biological activities, such as antioxidant, antidiabetic, anti-inflammatory, analgesic, antibacterial, antiviral, and antifungal effects. Particularly, two of its active phenolic compounds—rosmarinic acid and carvacrol—reveal notable anxiolytic and antidepressive properties.

A 2025 PMC review aimed to explore the capacity of S. montana to improve mental health through its phenolic components. Recent studies cited in the review indicate efficacy in addressing Alzheimer's-type dementia in preclinical models.

The dry extract of S. montana demonstrates considerable antioxidant properties, which play a vital role in alleviating oxidative stress, a prevalent factor in neuroinflammation and neurodegeneration. This antioxidant capability aids in neutralizing free radicals and diminishing reactive oxygen species, safeguarding neuronal cells from oxidative harm.

Principal component analysis of different extract types showed that extracts were closely associated with glucose-regulating effects, while essential oils clustered with enzyme-inhibiting neuroprotective activities. These findings highlight the multifunctional therapeutic potential of Satureja species and support their further investigation as candidates for the development of plant-derived agents against oxidative stress, diabetes, and neurodegenerative diseases.

Strength of evidence: Interesting mechanistic rationale via AChE/BChE inhibition and cytokine modulation in animal and cell-based studies. Evidence is early-stage; Satureja montana is recognized as a potential candidate for both the prevention and management of various mental health disorders, including dementia, but clinical confirmation in humans is absent.

5.5 Anticancer / Cytotoxic Activity

Evidence type: In vitro cell line studies and one animal model. No human trials.

Satureja montana has been studied as a medication in the treatment of several types of cancer in preclinical settings. Extracts suppressed the development of HT-29 (human colon adenocarcinoma) cells at concentrations over 0.7 mg/mL, and HeLa (human cervix epidermoid carcinoma) cells showed the maximum sensitivity to the savory extract.

One PMC study examined anticancer activity of S. montana supercritical and spray-dried extracts on Ehrlich's ascites carcinoma in mice. After application of the extracts, an increase in xanthine oxidase (XOD) activity, a decrease in catalase (CAT) activity, and an increase in lipid peroxidation intensity were observed. A decrease in values of reduced glutathione (GSH) in malignant cells was noted, as well as increases in glutathione reductase (GR) and glutathione peroxidase (GSHPx) after application of S. montana extract, suggesting that malignant cells were exposed to oxidative stress.

Several studies have shown significant cytotoxic activity of carvacrol and thymol against different cancer cell lines; furthermore, some authors have shown that minor components may play a role through synergistic effects.

Strength of evidence: Preclinical only. Cytotoxic effects in cell lines are well documented but in vitro cytotoxicity does not predict clinical efficacy. No human studies have been conducted.

5.6 Digestive System / Carminative Activity

Evidence type: Primarily traditional and ethnopharmacological; mechanistic rationale from preclinical data. No clinical RCTs identified.

While savory is most often used as a culinary herb, it also has marked medicinal benefits, especially upon the whole digestive system. Traditional medicine documentation records both summer and winter savory as having a history of use as tonics, carminatives, astringents, and expectorants, and for the treatment of intestinal problems such as diarrhea and nausea. The volatile oil constituents—particularly carvacrol and thymol—are believed to contribute antispasmodic and carminative activity by relaxing intestinal smooth muscle, though direct mechanistic studies specific to S. montana in human gut tissue are not established in the identified sources.

Strength of evidence: Well-supported traditional use across multiple cultures; mechanistic rationale is plausible given the phytochemistry. Controlled human evidence is lacking.

5.7 Antidiabetic / Hypoglycemic Activity

Evidence type: In vitro enzyme inhibition assays. No human clinical trials identified.

A recent PMC-indexed study evaluated the antidiabetic, antioxidant, and neuroprotective properties of various Satureja hortensis and Satureja montana extracts and essential oils. In vitro biological activities were assessed through α-glucosidase, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) inhibition assays, along with radical scavenging assays. Extracts were closely associated with glucose-regulating effects in principal component analysis.

Strength of evidence: In vitro only. Alpha-glucosidase inhibition is a surrogate marker for potential antidiabetic activity but does not confirm efficacy in humans.

5.8 Sexual Function (Premature Ejaculation)

Evidence type: Animal pharmacology study; patent application. No published human RCT identified.

A US patent application documents a study examining S. montana extracts for the treatment of premature ejaculation. Winter savory (Satureja montana) is known in traditional medicine as a remedy against asthenia or as an aphrodisiac. The stated object of the invention is the use of winter savory extracts, and of rosmarinic acid or extracts containing rosmarinic acid, for the preparation of medicaments for the treatment of premature ejaculation. The invention further encompasses a winter savory total extract for this purpose.

A PubMed-indexed experimental study on premature ejaculation in rats found that a significant increase in ejaculatory latency (EL) was found when the extract was subacutely administered daily for 8 consecutive days at the dose of 25 mg/kg.

Strength of evidence: Animal data only. No clinical trial has been published confirming efficacy in humans.

5.9 Antiviral Activity

Evidence type: In vitro / plant model studies.

An antiphytoviral study investigated the effects of S. montana essential oil and its major components thymol and carvacrol on Tobacco mosaic virus (TMV) and Cucumber mosaic virus (CMV). When applied simultaneously with the infecting virus, the number of local lesions on both TMV and CMV infected plants was reduced by 29.2% and 24.1%, respectively. Thymol was more effective in reducing CMV infection (33.2%), while carvacrol was more effective in reducing TMV infection (34.3%). The antiviral activity of savory essential oils against HIV has been documented in the literature, though the study types and design specifics of such HIV-related research require independent verification.

Strength of evidence: Very preliminary; plant virus model data and limited in vitro findings only. No human clinical data exist.

6. Body Systems Associated with Winter Savory

• Gastrointestinal system: Traditional use as carminative, antidiarrheal, antispasmodic, and digestive tonic; in vitro antimicrobial effects against enteric pathogens (E. coli, Salmonella, Campylobacter).
• Immune and infectious disease: Broad-spectrum antimicrobial and antifungal activity against bacteria (S. aureus, E. faecalis, K. pneumoniae), fungi (C. albicans, Aspergillus), and yeasts in vitro.
• Neurological system: Cholinesterase inhibitory activity; anxiolytic and antidepressive potential for rosmarinic acid and carvacrol in preclinical models; potential relevance to Alzheimer's disease.
• Musculoskeletal / inflammatory: Anti-inflammatory effects via COX inhibition and cytokine reduction in animal models; traditional use as topical remedy for arthritic joints.
• Respiratory system: Traditional use as expectorant and for sore throat; antimicrobial activity against respiratory pathogens.
• Endocrine / metabolic: Alpha-glucosidase inhibitory activity relevant to blood sugar; in vitro antidiabetic potential.
• Reproductive system: Preclinical data for premature ejaculation; traditional use as anaphrodisiac (winter savory) vs. aphrodisiac (summer savory).
• Oncology: Cytotoxic activity against cancer cell lines in vitro; prooxidant effects in malignant cells in animal models.

7. Dosage Forms and Reported Dosages

There are no established or officially approved human therapeutic dosages for winter savory as a medicinal agent. The following doses appear only in research contexts as cited:

• Dry extract, oral — animal study (chronic toxicity): Satureja montana dry extract was administered orally to male Wistar rats at a dose of 500 mg/kg body weight daily in a 90-day study; carvacrol was given at 500 mg/kg, and rosmarinic acid at 15 mg/kg.
• Dry extract, acute anti-inflammatory — animal study: The dry extract of Satureja montana was administered at a dosage of 250 mg/kg in a model of acute stress, markedly reducing pro-inflammatory cytokines.
• Plant extract, premature ejaculation — animal study: The extract was subacutely administered daily for 8 consecutive days at the dose of 25 mg/kg.
• Essential oil, antimicrobial MIC (in vitro): Minimal inhibitory concentrations ranged from 12.5 µg/mL against S. epidermidis to 50 µg/mL against P. aeruginosa and C. albicans.
• Decoction, antimicrobial MIC (in vitro): Satureja montana decoction presented MIC and MBC values of 1.56 mg/mL against S. aureus and K. pneumoniae.

No standardized human dosages have been established by official monographs (EMA, ESCOP, Commission E) for winter savory specifically; its use as a food spice and culinary herb at conventional culinary quantities is considered safe.

8. Safety Considerations and Interactions

General Safety Profile

Research reveals little or no information regarding adverse reactions with the use of savory at culinary doses. Savory is not associated with any significant toxicity.

In the 90-day rat toxicity study: Rosmarinic acid and small quantities of carvacrol were found in the dry extract. Full blood count and biochemical parameters including ASAT, ALAT, uric acid, cholesterol, triglycerides, glucose, and ionized Ca were within reference values. The histological samples showed no signs of organ toxicity. The main ingredient in the dry extract of Satureja montana is rosmarinic acid, and the extract is not toxic after 90 days of oral administration (at 500 mg/kg in rats).

Essential Oil: Concentration-Dependent Cytotoxicity

The toxic effect of the essential oil was reduced when formulated in oil/surfactant nanoemulsion preparations. Specifically, at 50 µg/mL, cytotoxicity decreased from approximately 50% to 25% when the essential oil was encapsulated in nanoemulsion. Several studies have shown significant cytotoxic activity of carvacrol and thymol against different cell lines, and minor components may contribute through synergistic effects. This underscores the importance of dilution when using the undiluted essential oil topically or internally.

Topical / Dermal Use

The essential oil of winter savory contains high concentrations of carvacrol and thymol, which are known phenolic irritants. Undiluted application to skin or mucous membranes is not appropriate given these constituents' warming and potentially irritant properties. This is consistent with the general finding that there have been several reports about the skin-sensitizing effect of essential oils; the spectrum of reported skin reactions includes contact dermatitis, irritant contact dermatitis, phototoxic reactions, and urticaria.

Pregnancy and Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking. Traditional phytotherapeutic sources note that winter savory infusions were used in folk medicine for uterine conditions; accordingly, use of therapeutic-dose preparations (beyond culinary amounts) in pregnancy is not supported by evidence.

Drug Interactions

No well-documented drug interactions have been established for savory. At a mechanistic level, the demonstrated synergistic antimicrobial interaction with gentamicin in vitro (SEO induced a synergistic interaction with gentamicin against both reference and clinical bacterial strains) raises theoretical considerations about additive pharmacodynamic effects with antibiotic therapy, though no clinical interaction studies in humans exist.

Antimicrobial Resistance Considerations

For hydrolates or their constituents to be a good alternative to synthetic antibiotics, it is necessary for them to have less of an environmental impact or less microbial resistance than that of treatments for many infectious diseases today. Essential oil components such as carvacrol appear to work via membrane disruption mechanisms that may be less prone to the development of resistance than single-target antibiotics, though this has not been formally verified in long-term resistance studies.

Misidentification and Species Confusion

Winter savory (S. montana) is sometimes confused with summer savory (S. hortensis). Winter savory is grown as a perennial, unlike its cousin summer savory, which is grown as an annual and tends to have a milder, less bitter flavor. Chemically, summer savory tends to be richer in thymol while winter savory is typically richer in carvacrol. This distinction matters pharmacologically, as their bioactive profiles differ quantitatively.

References

• Milinčić et al. "Variability in Biological Activities of Satureja montana Subsp. montana and Subsp. variegata Based on Different Extraction Methods." PMC, 2022.
• Elshafie et al. "Satureja montana L. essential oil and its antimicrobial activity alone or in combination with gentamicin." PubMed, 2018.
• Pires et al. "Antibiotic properties of Satureja montana L. hydrolate in bacteria and fungus of clinical interest." PMC, 2022.
• Kremer et al. "Antimicrobial and Antioxidant Properties of Satureja Montana L. and S. Subspicata Vis. (Lamiaceae)." PubMed, 2015.
• Pereira et al. "Satureja montana L. and Origanum majorana L. Decoctions: Antimicrobial Activity, Mode of Action and Phenolic Characterization." PubMed, 2020.
• Pereira et al. "Satureja montana L. and Origanum majorana L. Decoctions: Antimicrobial Activity, Mode of Action and Phenolic Characterization." PMC, 2020.
• Pereira et al. "Effect of the essential oils of Satureja montana L., Myristica fragrans H. and Cymbopogon flexuosus S. on mycotoxin-producing Aspergillus flavus and Aspergillus ochraceus." PubMed, 2021.
• Klančnik et al. "In Vitro Effect of the Common Culinary Herb Winter Savory (Satureja montana) against the Infamous Food Pathogen Campylobacter jejuni." PMC, 2020.
• Zeković et al. "Evaluation of Anticancer Activity of Satureja montana Supercritical and Spray-Dried Extracts on Ehrlich's Ascites Carcinoma Bearing Mice." PMC, 2020.
• Dragomanova et al. "Protective Potential of Satureja montana-Derived Polyphenols in Stress-Related Central Nervous System Disorders, Including Dementia." PMC, 2025.
• Mssillou et al. "Antioxidant, anti-amylase, anti-lipase, and efficiency of Satureja fatty acid on the anti-inflammatory parameters in lipopolysaccharide-stimulated macrophage through Nrf2/NF-kB/NADH oxidase pathway." PMC, 2024.
• Elshafie et al. "Satureja montana L. Essential Oils: Chemical Profiles/Phytochemical Screening, Antimicrobial Activity and O/W NanoEmulsion Formulations." PMC, 2020.
• Marić et al. "Antiphytoviral Activity of Satureja montana L. ssp. variegata Essential Oil and Phenol Compounds on CMV and TMV." PMC, 2018.
• Kitic et al. "Phytochemical composition and bioactivities of Satureja montana L. and Satureja hortensis L.: Culinary herbs with antidiabetic, anticholinesterase, and antioxidant potential." PMC, 2025.
• Cvetkovikj et al. "Cytotoxicity and antimicrobial activity of the essential oil from Satureja montana subsp. pisidica." PubMed, 2014.
• Durán Domínguez-de-Bazúa et al. "Experimental study on Satureja montana as a treatment for premature ejaculation." PubMed, 2011.
• Vilmosh et al. "Composition and chronic toxicity of dry methanol-aqueous extract of wild-growing Satureja montana." Folia Medica, 2023.
• Maryam et al. "Phytochemical profile, comparative evaluation of Satureja montana alcoholic extract for antioxidants, anti-inflammatory and molecular docking studies." BMC Complementary Medicine and Therapies, 2023.
• Drugs.com Natural Product Database. "Savory Uses, Benefits & Dosage." 2025.
• Wikipedia. "Winter savory (Satureja montana)."
• ScienceDirect Topics. "Winter Savory — Overview."
• Zivkovic et al. "A comprehensive review of summer savory (Satureja hortensis L.): promising ingredient for production of functional foods." PMC, 2023.
• Bonomi et al. "Effect of Satureja montana Essential Oil on Model Lipid Membranes." PMC, 2025.
• BMC Veterinary Research. "Anthelmintic activity of winter savory (Satureja montana L.) essential oil against gastrointestinal nematodes of sheep." 2025.